As of 2026-05-21, the Relative Valuation of Fulgent Genetics Inc (FLGT) is (76.04) USD. This relative valuation is based on P/E multiples. With the latest stock price at 16.41 USD, the upside of Fulgent Genetics Inc based on Relative Valuation is -563.4%.
The range of the Relative Valuation is (77.06) - (78.60) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.1x - 39.0x | 34.4x |
| Forward P/E multiples | 21.3x - 31.7x | 26.8x |
| Fair Price | (77.06) - (78.60) | (76.04) |
| Upside | -569.6% - -579.0% | -563.4% |
| Date | P/E |
| 2026-05-18 | -6.39 |
| 2026-05-15 | -6.33 |
| 2026-05-14 | -6.53 |
| 2026-05-13 | -6.43 |
| 2026-05-12 | -6.37 |
| 2026-05-11 | -6.38 |
| 2026-05-08 | -6.43 |
| 2026-05-07 | -6.09 |
| 2026-05-06 | -6.01 |
| 2026-05-05 | -6.01 |
| 2026-05-04 | -6.09 |
| 2026-05-01 | -5.70 |
| 2026-04-30 | -6.12 |
| 2026-04-29 | -5.97 |
| 2026-04-28 | -6.17 |
| 2026-04-27 | -6.29 |
| 2026-04-24 | -6.57 |
| 2026-04-23 | -6.46 |
| 2026-04-22 | -6.57 |
| 2026-04-21 | -6.42 |
| 2026-04-20 | -6.52 |
| 2026-04-17 | -6.55 |
| 2026-04-16 | -6.50 |
| 2026-04-15 | -6.52 |
| 2026-04-14 | -6.46 |
| 2026-04-13 | -6.17 |
| 2026-04-10 | -5.82 |
| 2026-04-09 | -6.05 |
| 2026-04-08 | -6.38 |
| 2026-04-07 | -6.41 |
| 2026-04-06 | -6.62 |
| 2026-04-02 | -6.78 |
| 2026-04-01 | -6.63 |
| 2026-03-31 | -6.41 |
| 2026-03-30 | -6.30 |
| 2026-03-27 | -6.28 |
| 2026-03-26 | -6.60 |
| 2026-03-25 | -6.72 |
| 2026-03-24 | -6.59 |
| 2026-03-23 | -6.58 |
| 2026-03-20 | -6.25 |
| 2026-03-19 | -6.27 |
| 2026-03-18 | -6.10 |
| 2026-03-17 | -6.22 |
| 2026-03-16 | -6.03 |
| 2026-03-13 | -5.95 |
| 2026-03-12 | -5.92 |
| 2026-03-11 | -5.79 |
| 2026-03-10 | -5.80 |
| 2026-03-09 | -6.00 |